Proteomic analysis of the supernatant of red blood cell units: The effects of storage and leucoreduction

Vox Sanguinis

Volumn 105, Issue 3, 2013, Pages 210-218

  Dzieciatkowska, M ^a   Silliman, C C ^a,b,c   Moore, E E ^a   Kelher, M R ^a,b   Banerjee, A ^a   Land, K J ^d   Ellison, M ^b   West, F B ^b   Ambruso, D R ^b,c   Hansen, K C ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Bonfils Blood Center   (United States)

^c Children's Hospital Colorado   (United States)

^d Blood Systems   (United States)

Author keywords

Leucoreduction; Proteins; Red blood cell; Storage; Supernatant; Transfusion

Indexed keywords

CELL PROTEIN; CYSTATIN C; GELATINASE B; LATEXIN; METALLOPROTEINASE INHIBITOR; METALLOPROTEINASE INHIBITOR 1; PEROXIREDOXIN 6; PHOSPHOLIPASE; PROTEIN; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD STORAGE; CELL STRUCTURE; CONTROLLED STUDY; DIGESTION; ENZYME ACTIVITY; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; HUMAN; HUMAN CELL; IN GEL TRYPTIC DIGESTION; LEUCOREDUCED RED BLOOD CELL; LEUKOCYTE; LIQUID CHROMATOGRAPHY; MEDIATOR; NANOLIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEOMICS; SUPERNATANT; TANDEM MASS SPECTROMETRY; THROMBOCYTE; WESTERN BLOTTING;

LEUCOREDUCTION; PROTEINS; RED BLOOD CELL; STORAGE; SUPERNATANT; TRANSFUSION;

BLOOD PLATELETS; BLOOD PRESERVATION; BLOOD PROTEINS; CRITICAL ILLNESS; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; FEMALE; HUMANS; LEUKOCYTE COUNT; LEUKOCYTES; MALE; MASS SPECTROMETRY; PROTEOMICS; TIME FACTORS;

EID: 84884279369     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12042     Document Type: Article

References (57)

1. Popovsky MA (ed): Transfusion Reactions: Bethesda, 3rd edn. Bethesda, MD, AABB Press, 2007
2. Koch CG, Li L, Sessler DI, et al.: Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358:1229-1239
3. Purdy FR, Tweeddale MG, Merrick PM: Association of mortality with age of blood transfused in septic ICU patients. Can J Anaesth 1997; 44:1256-1261
4. Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al.: Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003; 101:454-462
5. Weinberg JA, McGwin G Jr, Griffin RL, et al.: Age of transfused blood: an independent predictor of mortality despite universal leukoreduction. J Trauma 2008; 65:279-282
6. Zallen G, Offner PJ, Moore EE, et al.: Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am J Surg 1999; 178:570-572
7. Blumberg N, Heal JM, Gettings KF, et al.: An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions. Transfusion 2010; 50:2738-2744
8. Hebert PC, Fergusson D, Blajchman MA, et al.: Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA 2003; 289:1941-1949
9. Khan SY, Kelher MR, Heal JM, et al.: Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006; 108:2455-2462
10. Wyman TH, Dinarello CA, Banerjee A, et al.: Physiological levels of interleukin-18 stimulate multiple neutrophil functions through p38 MAP kinase activation. J Leukoc Biol 2002; 72:401-409
11. Kelher MR, Masuno T, Moore EE, et al.: Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model. Blood 2009; 113:2079-2087
12. Silliman CC, Clay KL, Thurman GW, et al.: Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med 1994; 124:684-694
13. Silliman CC, Paterson AJ, Dickey WO, et al.: The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion 1997; 37:719-726
14. Silliman CC, Moore EE, Kelher MR, et al.: Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury. Transfusion 2011; 51:2549-2554
15. Ambruso DR, Ellison MA, Thurman GW, et al.: Peroxiredoxin 6 translocates to the plasma membrane during neutrophil activation and is required for optimal NADPH oxidase activity. Biochim Biophys Acta 2012; 1823:306-315
16. Silliman CC, Kelher M, Ambruso DR: Bioactive lipids from stored cellular blood components: in vitro method is crucial for proper interpretation. Transfusion 2012; 52:1155-1157
17. Bercovitz RS, Kelher MR, Khan SY, et al.: The pro-inflammatory effects of platelet contamination in plasma and mitigation strategies for avoidance. Vox Sang 2011; 102:345-353
18. Dzieciatkowska M, Wohlauer MV, Moore EE, et al.: Proteomic analysis of human mesenteric lymph. Shock 2011; 35:331-338
19. Silliman CC, Dzieciatkowska M, Moore EE, et al.: Proteomic analyses of human plasma: Venus versus Mars. Transfusion 2012; 52:417-424
20. Old WM, Meyer-Arendt K, Aveline-Wolf L, et al.: Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol Cell Proteomics 2005; 4:1487-1502
21. Griffin NM, Yu J, Long F, et al.: Label-free, normalized quantification of complex mass spectrometry data for proteomic analysis. Nat Biotechnol 2010; 28:83-89
22. Pavlidis P, Noble WS: Matrix2png: a utility for visualizing matrix data. Bioinformatics 2003; 19:295-296
23. McLaughlin NJ, Banerjee A, Kelher MR, et al.: Platelet-activating factor-induced clathrin-mediated endocytosis requires beta-arrestin-1 recruitment and activation of the p38 MAPK signalosome at the plasma membrane for actin bundle formation. J Immunol 2006; 176:7039-7050
24. Shim YJ, Kang BH, Jeon HS, et al.: Clusterin induces matrix metalloproteinase-9 expression via ERK1/2 and PI3K/Akt/NF-kappaB pathways in monocytes/macrophages. J Leukoc Biol 2011; 90:761-769
25. al-Turk WA, Stohs SJ, el-Rashidy FH, et al.: Glutathione, glutathione S-transferase and glutathione reductase in human erythrocytes and lymphocytes as a function of sex. Drug Des Deliv 1987; 1:237-243
26. Deisseroth A, Dounce AL: Catalase: Physical and chemical properties, mechanism of catalysis, and physiological role. Physiol Rev 1970; 50:319-375
27. Ketterer B: Glutathione S-transferases and prevention of cellular free radical damage. Free Radic Res 1998; 28:647-658
28. Mentzer WCJ: Pyruvate kinase deficiency and disorders of glycolysis; in Nathan DG, Oski FA (eds): Hematology of Infancy and Childhood, 4th edn. Philadelphia, W.B. Saunders Company, 2012:634-673
29. Liang Y, Jansen M, Aronow B, et al.: The quantitative trait gene latexin influences the size of the hematopoietic stem cell population in mice. Nat Genet 2007; 39:178-188
30. Wu Y, Feinstein SI, Manevich Y, et al.: Mitogen-activated protein kinase-mediated phosphorylation of peroxiredoxin 6 regulates its phospholipase A(2) activity. Biochem J 2009; 419:669-679
31. Chatterjee S, Feinstein SI, Dodia C, et al.: Peroxiredoxin 6 phosphorylation and subsequent phospholipase A2 activity are required for agonist-mediated activation of NADPH oxidase in mouse pulmonary microvascular endothelium and alveolar macrophages. J Biol Chem 2011; 286:11696-11706
32. Leavey PJ, Gonzalez-Aller C, Thurman G, et al.: A 29-kDa protein associated with p67phox expresses both peroxiredoxin and phospholipase A2 activity and enhances superoxide anion production by a cell-free system of NADPH oxidase activity. J Biol Chem 2002; 277:45181-45187
33. Abdul-Hussien H, Soekhoe RG, Weber E, et al.: Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases. Am J Pathol 2007; 170:809-817
34. Jackson PL, Xu X, Wilson L, et al.: Human neutrophil elastase-mediated cleavage sites of MMP-9 and TIMP-1: implications to cystic fibrosis proteolytic dysfunction. Mol Med 2010; 16:159-166
35. Anniss AM, Glenister KM, Killian JJ, et al.: Proteomic analysis of supernatants of stored red blood cell products. Transfusion 2005; 45:1426-1433
36. Mangeat P, Burridge K: Actin-membrane interaction in fibroblasts: what proteins are involved in this association? J Cell Biol 1984; 99:95s-103s
37. Nieswandt B, Varga-Szabo D, Elvers M: Integrins in platelet activation. J Thromb Haemost 2009; 7(Suppl. 1):206-209
38. Oikonomou KG, Zachou K, Dalekos GN: Alpha-actinin: a multidisciplinary protein with important role in B-cell driven autoimmunity. Autoimmun Rev 2011; 10:389-396
39. Lopez-Alemany R, Suelves M, Munoz-Canoves P: Plasmin generation dependent on alpha-enolase-type plasminogen receptor is required for myogenesis. Thromb Haemost 2003; 90:724-733
40. Wygrecka M, Marsh LM, Morty RE, et al.: Enolase-1 promotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung. Blood 2009; 113:5588-5598
41. Blom AM, Villoutreix BO, Dahlback B: Complement inhibitor C4b-binding protein-friend or foe in the innate immune system? Mol Immunol 2004; 40:1333-1346
42. Dean MM, Flower RL, Eisen DP, et al.: Mannose-binding lectin deficiency influences innate and antigen-presenting functions of blood myeloid dendritic cells. Immunology 2011; 132:296-305
43. Hathaway WE, Goodnight SH: Disorders of Hemostasis and Thrombosis: A Clinical Guide, 1st edn. New York, McGraw-Hill, Inc, 1993
44. Rinalducci S, D'Amici GM, Blasi B, et al.: Peroxiredoxin-2 as a candidate biomarker to test oxidative stress levels of stored red blood cells under blood bank conditions. Transfusion 2011; 51:1439-1449
45. Antunes RF, Brandao C, Maia M, et al.: Red blood cells release factors with growth and survival bioactivities for normal and leukemic T cells. Immunol Cell Biol 2011; 89:111-121
46. Arora P, Ricks TK, Trejo J: Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer. J Cell Sci 2007; 120:921-928
47. Babovic-Vuksanovic D, Snow K, Ten RM: Mannose-binding lectin (MBL) deficiency. Variant alleles in a midwestern population of the United States. Ann Allergy Asthma Immunol 1999; 82:134-138, 141
48. Friedland RP: Lipid metabolism, epidemiology, and the mechanisms of Alzheimer's disease. Ann N Y Acad Sci 2002; 977:387-390
49. Gomez DE, Alonso DF, Yoshiji H, et al.: Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997; 74:111-122
50. Martin P, Lerner A, Johnson L, et al.: Inherited mannose-binding lectin deficiency as evidenced by genetic and immunologic analyses: association with severe recurrent infections. Ann Allergy Asthma Immunol 2003; 91:386-392
51. Nelson AR, Fingleton B, Rothenberg ML, et al.: Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 2000; 18:1135-1149
52. Schreiber G, Richardson SJ: The evolution of gene expression, structure and function of transthyretin. Comp Biochem Physiol B Biochem Mol Biol 1997; 116:137-160
53. Ye S: Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol 2000; 19:623-629
54. Bercovitz RS, Andrews J, Dietz A, et al.: Blood component utilization in pediatric stem cell patients in the first 100 days post-transplant, Pediatric Blood & Cancer, 2011; 56:904
55. Kim-Shapiro DB, Lee J, Gladwin MT: Storage lesion: role of red blood cell breakdown. Transfusion 2011; 51:844-851
56. Jeffery CJ: Moonlighting proteins: old proteins learning new tricks. Trends Genet 2003; 19:415-417
57. Jeffery CJ: Moonlighting proteins-an update. Mol BioSyst 2009; 5:345-350